-
1
المؤلفون: P. Martin van Hagen, Jan A. M. van Laar, Christel E. van Bilsen, Tom Missotten, Johannes R. Vingerling, Nico J. Veeger, Paul L A van Daele, G. Seerp Baarsma, Marianne W. van der Ent, Robert W A M Kuijpers
المساهمون: Internal Medicine, Ophthalmology, Immunology, Hematology, Life Course Epidemiology (LCE), Surgical clinical sciences
المصدر: Acta Ophthalmologica, 92(8), e691-e692. Wiley-Blackwell Publishing Ltd
Acta ophthalmologica, 92(8), e691-e692. Wileyمصطلحات موضوعية: Medicine(all), Visual Acuity/drug effects, Tumor Necrosis Factor-alpha, business.industry, medicine.drug_class, Administration, Topical, Exudates and Transudates, General Medicine, Antibodies, Monoclonal/adverse effects, Contrast Sensitivity/drug effects, Exudative age-related macular degeneration, Monoclonal antibody, Infliximab, Wet Macular Degeneration/drug therapy, Ophthalmology, Anti tnf α, Immunology, medicine, Humans, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Ophthalmic Solutions, infliximab, business, Aged, medicine.drug